Management of dupilumab-related ocular surface disorders

被引：0
|
作者：
Felfeli, Tina [1 ,2 ]
Drucker, Aaron M. [2 ,3 ,4 ]
机构：
[1] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada
[2] Univ Toronto, Inst Hlth Policy Management & Evaluat, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[3] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada
[4] Womens Coll Hosp, Dept Med & Res & Innovat Inst, Div Dermatol, Toronto, ON, Canada
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 191卷 / 06期
关键词：
D O I：
10.1093/bjd/ljae350
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：857 / 858
页数：2
相关论文
共 50 条
  • [1] An expert consensus on managing dupilumab-related ocular surface disorders in people with atopic dermatitis 2024
    Ardern-Jones, Michael R.
    Brown, Sara J.
    Flohr, Carsten
    Hossain, Parwez
    Irvine, Alan D.
    Johnston, Graham A.
    Lane, Mark
    Langan, Sinead M.
    Laws, Philip
    O'Driscoll, Daniel
    O'Kane, Donal
    Payne, Alice
    Petrof, Gabriela
    Pink, Andrew E.
    Rauz, Saaeha
    Robbie, Scott
    Gore, Sri K.
    Shah, Mili
    Woolf, Richard T.
    Wang, Chenxi
    Tumbeva, Stoyana
    Mustapa, M. Firouz Mohd
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 (06) : 865 - 885
  • [2] Dupilumab-related ocular surface disorders in a paediatric cohort with atopic dermatitis, treated in a tertiary paediatric hospital in London
    Rampersad, Anjali
    Gholam, Karolina
    Solman, Lea
    Cartledge, Natalia
    Gore, Sri
    Petrof, Gabriela
    JEADV CLINICAL PRACTICE, 2024, 3 (05): : 1558 - 1563
  • [3] Clinical characteristics and treatment for dupilumab-related ocular complications in atopic dermatitis patients
    Jinno, Stephanie E.
    Chung, Caroline W.
    Tauqeer, Zujaja
    Massaro-Giordano, Mina
    Bunya, Vatinee Y.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [4] Clinical Characteristics and Treatment for Dupilumab-Related Ocular Complications in Atopic Dermatitis Patients
    Tauqeer, Zujaja
    Jinno, Stephanie E.
    Chung, Caroline W.
    Massaro-Giordano, Mina
    Bunya, Vatinee Y.
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 947 - 958
  • [5] Analyses of Dupilumab-Related Ocular Adverse Drug Reactions Using the WHO’s VigiBase
    Eri Hirai
    Tomoko Haruki
    Takashi Baba
    Dai Miyazaki
    Advances in Therapy, 2023, 40 : 3830 - 3856
  • [6] Analyses of Dupilumab-Related Ocular Adverse Drug Reactions Using the WHO's VigiBase
    Hirai, Eri
    Haruki, Tomoko
    Baba, Takashi
    Miyazaki, Dai
    ADVANCES IN THERAPY, 2023, 40 (09) : 3830 - 3856
  • [7] A case of dupilumab-related tendinitis and tendon rupture
    Cheong, K.
    Yew, Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S184 - S184
  • [8] Demodex palpebral infestation in dupilumab-related blepharoconjunctivitis
    Doan, S.
    Jachiet, M.
    Crepy, M. N.
    Bouaziz, J. D.
    Cochereau, I
    Descamps, V
    Soria, A.
    ALLERGY, 2020, 75 : 326 - 327
  • [9] Dupilumab-related blepharoconjunctivitis in patients with severe atopic dermatitis
    Doan, S.
    Fares, S.
    Cochereau, I
    Soria, A.
    ALLERGY, 2019, 74 : 183 - 183
  • [10] Dupilumab-related blepharoconjunctivitis: Recommendations of the CEDRE group. Atopic dermatitis, conjunctivitis and dupilumab: Which management approach?
    Doan, S.
    Arnould, L.
    Febvay, C.
    Fournie, P.
    Gueudry, J.
    Labalette, P.
    Ouilhon, C.
    Tran, T-H-C
    Vabres, B.
    Barbarot, S.
    Bouaziz, J-D
    Du-Thanh, A.
    Jachiet, M.
    Seneschal, J.
    Soria, A.
    Staumont-Salle, D.
    Baudouin, C.
    Mortemousque, B.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2022, 45 (03): : 277 - 287
12345